Imaging of lung cancer resistance to EGFR tyrosine kinase inhibitors through Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3

被引：0
|
作者：
Zannetti, A. [1 ]
Iommelli, F. [1 ]
Fonti, R. [1 ]
Papaccioli, A. [1 ]
Sommella, J. [1 ]
Lettieri, A. [1 ]
Bianco, R. [2 ]
Tortora, G. [2 ]
Salvatore, M. [3 ]
Del Vecchio, S. [3 ]
机构：
[1] CNR, Inst Biostruct & Bioimages, Naples, Italy
[2] Univ Naples Federico II, Dept Endocrinol & Mol & Clin Oncol, Naples, Italy
[3] Univ Naples Federico II, Dept Biomorphol & Funct Sci, Naples, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2008年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S187 / S187
页数：1
相关论文
共 50 条
  • [31] Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPAR-γ
    Shiau, CW
    Yang, CC
    Kulp, SK
    Chen, KF
    Chen, CS
    Huang, JW
    Chen, CS
    CANCER RESEARCH, 2005, 65 (04) : 1561 - 1569
  • [32] Discovery of potent inhibitors of the antiapoptotic proteins Bcl-2 and Bcl-xL, resulting in the identification of a clinical candidate for the treatment of cancer (AZD4320)
    Hennessy, Edward
    Ioannidis, Stephanos
    Adam, Ammar
    Brassil, Patrick
    Byth, Kate
    Clark, Edwin
    Diebold, R.
    Dillman, Keith
    Gero, Thomas
    Grover, Paul
    Huang, Shan
    Lewis, Paula
    MacIntyre, Terry
    Ogoe, Claude
    Powell, Francoise
    Repik, Galina
    Russell, Daniel
    Saeh, Jamal
    Schroeder, Patricia
    Secrist, Paul
    Su, Mei
    Varnes, Jeffrey
    Zhang, Weijia
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [33] PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer
    Khan, Sajid
    Cao, Lin
    Wiegand, Janet
    Zhang, Peiyi
    Zajac-Kaye, Maria
    Kaye, Frederic J.
    Zheng, Guangrong
    Zhou, Daohong
    CELLS, 2024, 13 (06)
  • [34] Dracorhodin perchlorate induces apoptosis in bladder cancer cells through Bcl-2, Bcl-XL, survivin down-regulation and caspase-3 activation
    Wei, Wei
    Di, Jun
    Rasul, Azhar
    Zhao, Chaoyue
    Millimouno, Faya Martin
    Tsuji, Ichiro
    Iqal, Furhan
    Malhi, Mahadev
    Li, Xiaomeng
    Li, Jiang
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2013, 8 (03) : 276 - 282
  • [35] Co-inhibition of BCL-XL and MCL-1 with selective BCL-2 family inhibitors enhances cytotoxicity of cervical cancer cell lines
    Rahman, Siti Fairus Abdul
    Muniandy, Kalaivani
    Soo, Yong Kit
    Tiew, Elvin Yu Huai
    Tan, Ke Xin
    Bates, Timothy E.
    Mohana-Kumaran, Nethia
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2020, 22
  • [36] IL-4-dependent induction of Bcl-2 and Bcl-XL in activated T lymphocytes through a Stat6-and PI 3-kinase-independent pathway
    Aronica, MA
    Goenka, S
    Boothby, M
    CYTOKINE, 2000, 12 (06) : 578 - 587
  • [37] Radiation enhances the efficacy of Bcl-2 and Bcl-XL inhibition in small cell lung cancer: A new concept of using radiation for targeted therapy through contextual oncogene addiction
    Loriot, Yohann
    Mordant, Pierre
    Dugue, Delphine
    Gombos, Andrea
    Opolon, Paule
    Vozenin, Marie-Catherine
    Bourhis, Jean
    Geneste, Olivier
    Kraus-Berthier, Laurence
    Pierre, Alain
    Depil, Stephane
    Soria, Jean-Charles
    Deutsch, Eric
    CANCER RESEARCH, 2012, 72
  • [38] Combined inhibition of Bcl-2 and MCL-1 in small cell lung cancer (SCLC) is most effective in tumors with low Bcl-xL expression
    Drapkin, Benjamin J.
    Sanghavi, Sneha
    Myers, David T.
    Zhong, Jun
    Phat, Sarah
    Wang, Youzhen
    Halilovic, Ensar
    Golji, Javad
    Farago, Anna
    Morris, Erick
    Dyson, Nicholas J.
    CANCER RESEARCH, 2019, 79 (13)
  • [39] Interaction of BCl-XL with mammalian types-1 and 3 inositol 1,4,5-trisphosphate receptor Ca2+-release channel.
    Li, Chi
    Vais, Horia
    Thompson, Craig B.
    Foskett, Kevin
    White, Carl
    BIOPHYSICAL JOURNAL, 2007, : 446A - 446A
  • [40] MTORC1/2 inhibition in combination with BCL-2/BCL-xL inhibition in APC and PIK3CA mutant colorectal cancer
    Fricke, Stephanie L.
    Payne, Susan N.
    Pasch, Cheri A.
    Korkos, Demetra P.
    Sha, Gioia
    Yueh, Alex E.
    Babiarz, Christopher
    Clipson, Linda
    Matkowskyj, Kristina A.
    Newton, Michael A.
    Deming, Dustin A.
    CANCER RESEARCH, 2018, 78 (13)
12345